Liver Assessment

The pattern of abnormal results helps indicate which liver process requires attention. Aminotransferases reflect hepatocellular damage, whereas alkaline phosphatase and bilirubin provide information about cholestasis, meaning impaired bile flow. Interpreting these measures together is more informative than considering one result alone because they represent different aspects of liver injury and function.

Albumin and prothrombin time provide information about the liver’s synthetic capacity, or its ability to produce important blood proteins. These measures complement markers of cellular injury and bile flow, helping clinicians evaluate functional impairment rather than relying only on evidence of tissue damage. Their inclusion therefore broadens the clinical picture of liver status.

Ultrasound contributes structural and circulatory information that blood tests cannot provide directly. It can be used to assess liver anatomy and blood flow, while laboratory measurements indicate injury, cholestasis, bilirubin handling, or synthetic capacity. Combining these perspectives helps clinicians relate functional abnormalities to possible changes in hepatic structure and circulation.

No single component captures every clinically relevant feature of liver disease. Medical history and physical examination provide clinical context, blood tests describe injury, bile flow, and synthetic function, and imaging evaluates anatomy and blood flow. Integrating these findings supports a more complete assessment and helps guide decisions about diagnosis, treatment, and follow-up.

Clinicians begin by gathering medical history and performing a physical examination, then use liver blood tests to evaluate injury, cholestasis, and synthetic capacity. Ultrasound or other imaging may assess anatomy and blood flow. When the cause or severity remains uncertain, specialized tests or biopsy can provide additional clarification.

Specialized tests or biopsy may be used when routine clinical information, blood tests, and imaging do not sufficiently clarify the cause or severity of liver disease. In that setting, they provide additional evidence for clinical assessment. Their role is therefore to resolve remaining uncertainty and support more specific diagnostic or management decisions.

An integrated assessment can help clinicians identify the nature and extent of liver disease, select an appropriate treatment approach, and monitor progression over time. Repeated evaluation also helps determine whether a patient is responding to therapy. This makes liver assessment relevant not only at diagnosis, but throughout ongoing clinical care.